MBX - CIK 0001776111
MBX Biosciences, Inc. trades as MBX and has a market capitalization of $1.43 B, making it the #2364 largest US-listed company by market value. This page tracks MBX Biosciences, Inc. through 198 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-08 |
| Proxy materials | DEFA14A | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
The largest companies sharing MBX Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
MBX Biosciences, Inc. (MBX) has a market capitalization of $1.43 B as of 2026-06-10, ranking #2364 among US-listed companies.
In its latest fiscal year MBX Biosciences, Inc. reported a net loss of $87.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.